BackgroundTo investigate whether the administration of hydrogen/oxygen mixture was superior to oxygen in improving symptoms in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
MethodsThis prospective, randomized, double-blind, controlled clinical trial in 10 centres enrolled patient with AECOPD and … Continue Reading ››
Although ionizing radiation (radiation) is commonly used for medical diagnosis and
cancer treatment, radiation-induced damages cannot be avoided. Such damages can be classified
into direct and indirect damages, caused by the direct absorption of radiation energy into DNA and
by free radicals, such as hydroxyl radicals (OH), generated in the process of water radiolysis. More
specifically, radiation damage concerns not only direct damages to DNA, but also secondary damages
to non-DNA targets, because low-dose radiation damage is mainly caused by these indirect effects.
Molecular hydrogen (H2) has the potential to be a radioprotective agent because it can selectively
scavenge OH, a reactive oxygen species with strong oxidizing power. Animal experiments and
clinical trials have reported that H2 exhibits a highly safe radioprotective effect. This paper reviews
previously reported radioprotective effects of H2 and discusses the mechanisms of H2, not only as
an antioxidant, but also in intracellular responses including anti-inflammation, anti-apoptosis, and
the regulation of gene expression. In doing so, we demonstrate the prospects of H2 as a novel and
clinically applicable radioprotective agent.
Parkinson disease (PD), the second most common neurodegenerative disease, has no cure or applicable disease-modifying approach, only symptomatic therapy. Oxidative stress and mitochondrial dysfunction play key roles in PD pathophysiology. Animal studies have demonstrated that photobiomodulation (PBM) may enhance mitochondrial … Continue Reading ››
Sixty subjects were randomly assigned to placebo (PBO) group or hydrogen H2-rich water (HRW) group and drank either bottled pure water or hydrogen H2-rich water (245 mL/time, 3 times/d) for ten weeks.
Results The pulse wave velocity was ameliorated in the hydrogen water HRW group with no significant change in the ankle-brachial index. The serum total cholesterol of the hydrogen water HRW group was significantly reduced compared to the placebo group. In addition, compared to baseline, the levels of lipoprotein(a) was decreased, the malondialdehyde content was reduced, the superoxide dismutase activity was increased, and the expression of intercellular cell adhesion molecule-1 was decreased significantly in the hydrogen water HRW group. The oxidized phospholipid of 1-palmitoyl-2-azelaoyl-sn-glycero-3-phosphatidylcholine level in the hydrogen water HRW group were significantly reduced compared to the placebo group. Finally, hydrogen water H2 significantly improved the antioxidant, antiinflammatory, and antiapoptotic abilities of high-density lipoprotein (HDL).
Conclusions Drinking hydrogen water HRW can improve vascular sclerosis indicators, improve dyslipidemia, reduce vascular oxidative stress and inflammation, and improve HDL function. hydrogen water H2 may be used to prevent and relieve PAD caused by major risk factors such as smoking, hypertension, hyperlipidemia, and diabetes.
The evidence for the beneficial effects of drinking hydrogen-water (HW) is rare. We aimed to investigate the effects of HW consumption on oxidative stress and immune functions in healthy adults using systemic approaches of biochemical, cellular, and molecular nutrition. In a randomized, double-blind, placebo-controlled study, healthy adults (20–59 y) consumed either 1.5 L/d of HW (n = 20) or plain water (PW, n = 18) for 4 weeks. The changes from baseline to the 4th week in serum biological antioxidant potential (BAP), derivatives of reactive oxygen, and 8-Oxo-2′-deoxyguanosine did not differ between groups; however, in those aged ≥ 30 y, BAP increased greater in the HW group than the PW group. Apoptosis of peripheral blood mononuclear cells (PBMCs) was significantly less in the HW group. Flow cytometry analysis of CD4+, CD8+, CD20+, CD14+ and CD11b+ cells showed that the frequency of CD14+ cells decreased in the HW group. RNA-sequencing analysis of PBMCs demonstrated that the transcriptomes of the HW group were clearly distinguished from those of the PW group. Most notably, transcriptional networks of inflammatory responses and NF-κB signaling were significantly down-regulated in the HW group. These finding suggest HW increases antioxidant capacity thereby reducing inflammatory responses in healthy adults.
UltraWater Testing expanded by 45% to 249 Contaminants, including "Forever Chemicals"!